Prevention of end-stage renal disease due to type 2 diabetes

N Engl J Med. 2001 Sep 20;345(12):910-2. doi: 10.1056/NEJM200109203451209.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Antihypertensive Agents / therapeutic use*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / prevention & control
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Kidney Failure, Chronic / prevention & control*

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents